Inhibition of Axitinib on Buspirone Metabolism in vitro and in vivo
Bo-Wen Zhang,1 Ni-Hong Pang,2 Ren-Ai Xu,1 Gao-Er Qu,3 Cong-Rong Tang1 1Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People’s Republic of China; 2Department of Pharmacy, The Third Affiliated Hospital of Shanghai University (Wenzhou People’s Hospital),...
Main Authors: | Zhang BW, Pang NH, Xu RA, Qu GE, Tang CR |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-06-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/inhibition-of-axitinib-on-buspirone-metabolism-in-vitro-and-in-vivo-peer-reviewed-fulltext-article-DDDT |
Similar Items
-
Buspirone-associated Movement Disorder: A Literature Review
by: Jamir Pitton Rissardo, et al.
Published: (2020-03-01) -
Differences Between the Prenatal Effects of Fluoxetine or Buspirone Alone or in Combination on Pain and Affective Behaviors in Prenatally Stressed Male and Female Rats
by: Irina P. Butkevich, et al.
Published: (2019-06-01) -
Quetiapine and buspirone both elevate cortical levels of noradrenaline and dopamine in vivo, but do not have synergistic effects
by: Peter H Silverstone, et al.
Published: (2012-09-01) -
Side effects and cognitive benefits of buspirone: A systematic review and meta-analysis
by: Yue Du, et al.
Published: (2024-04-01) -
Possible modulation of the antidiabetic effect of rosiglitazone by buspirone
by: Wafaa R. Mohamed, et al.
Published: (2012-06-01)